Roche and Molecular Partners have entered into a research and licensing alliance to discover, develop and commercialize new cancer treatments. The agreement will incorporate Molecular Partners ...

WHO's EUL process is based on a thorough evaluation of quality, safety, and performance data, ensuring compliance with ...

The new test is compatible with Roche's cobas 5800, 6800, and 8800 molecular diagnostic analysers, which are widely used in hospitals and other clinical settings, without any need for upgrades.

The base business in this division grew 8%, driven by demand for immunodiagnostic, pathology and molecular solutions products. Roche’s shares have risen 8.2% year to date compared with the ...